AOD-9604 is primarily known for its fat-burning effects and body composition improvement, but may offer some potential joint health benefits, though research is limited
doi: 10.3892/mmr.2017.7299 304 WooSJLeeSMLimHSHahYSJungIDParkYMet al
The medication's mechanism of slowing gastric emptying and affecting gut motility can lead to significant gastrointestinal disturbances, particularly during treatment initiation and dose escalation phases
Ketone bodies directly reduce hunger signals
Similarly, in patients with breast cancer, the inhibition of GPX3 expression through promoter hypermethylation has been associated with the proliferation, migration and invasion of tumor cells
Weight loss results: In clinical trials, oral semaglutide 25 mg achieved 13.6% total body weight loss at 64 weeks while injectable semaglutide 2.4 mg achieved 14.9% total body weight loss at 68 weeks